RETRACTED: Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: In-vitro, ex-vivo and in-vivo studies (International Journal of Pharmaceutics: X (2023) 5, (S259015672300018X), (10.1016/j.ijpx.2023.100174))

  • Sammar Fathy Elhabal
  • , Shrouk A. Ghaffar
  • , Raghda Hager
  • , Nahla A. Elzohairy
  • , Mohamed Mansour Khalifa
  • , Passant M. Mohie
  • , Rania A. Gad
  • , Nasreen N. Omar
  • , Mohammed H. Elkomy
  • , Mohammad Ahmad Khasawneh
  • , Nashwa Abdelaal

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Concern had been raised about inconsistencies in the figures and image similarities between figures. Image analysis performed by the editorial office confirmed findings of image duplications between subfigures in Figs. 9 and 10, and between Figs. 14 and 15. The authors failed to provide a satisfactory explanation during the investigation.

Original languageEnglish
Article number100270
JournalInternational Journal of Pharmaceutics: X
Volume8
DOIs
Publication statusPublished - Dec 2024

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'RETRACTED: Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: In-vitro, ex-vivo and in-vivo studies (International Journal of Pharmaceutics: X (2023) 5, (S259015672300018X), (10.1016/j.ijpx.2023.100174))'. Together they form a unique fingerprint.

Cite this